Intravenous iron treatments for iron deficiency anemia in inflammatory bowel disease: a budget impact analysis of iron isomaltoside 1000 (Monofer) in the UK

The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency

(2017) Svein Oskar Frigstad et al.   Gastroenterology Research and Practice

An analysis of product wastage arising from dosing increment granularity in four modern growth hormone administration devices

(2015) Richard F Pollock et al.   Expert Opinion on Drug Delivery

European Consensus on the Diagnosis and Management of Iron Deficiency and Anaemia in Inflammatory Bowel Diseases

(2015) Axel U Dignass et al.   Journal of Crohns & Colitis

The epidemiology of inflammatory bowel disease

(2015) Johan Burisch et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis

(2015) Italia Loddo et al.   Frontiers in Immunology

Prevalence of Anemia in Inflammatory Bowel Diseases in European Countries

(2014) Natalie Filmann et al.   INFLAMMATORY BOWEL DISEASES

A Cost Of Care Model For Inflammatory Bowel Disease With A Uk Nhs Perspective

(2014) G. Miles et al.   VALUE IN HEALTH

Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force

(2013) Sean D. Sullivan et al.   VALUE IN HEALTH

Cost-Minimization Analysis Favours Intravenous Ferric Carboxymaltose over Ferric Sucrose for the Ambulatory Treatment of Severe Iron Deficiency

(2012) Xavier Calvet et al.   PLoS One

A hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000

(2012) Sunil Bhandari   Therapeutics and Clinical Risk Management

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia

(2011) Michael Auerbach et al.   AMERICAN JOURNAL OF HEMATOLOGY

FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease

(2011) Rayko Evstatiev et al.   GASTROENTEROLOGY

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

(2011) Natalie A. Molodecky et al.   GASTROENTEROLOGY

Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice

(2011) Sunil Bhandari   Therapeutics and Clinical Risk Management

Rapid Recurrence of IBD-Associated Anemia and Iron Deficiency After Intravenous Iron Sucrose and Erythropoietin Treatment

(2009) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial

(2008) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY